SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
about
Mammary Development and Breast Cancer: A Wnt PerspectiveStratification and therapeutic potential of PML in metastatic breast cancerExpression and Therapeutic Potential of SOX9 in Chordoma.Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma.Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.CDK7-dependent transcriptional addiction in triple-negative breast cancer.The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cellsThe biology of castration-resistant prostate cancerIdentification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.β-catenin and Kras/Foxm1 signaling pathway are critical to restrict Sox9 in basal cells during pulmonary branching morphogenesisHistone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signalingTwist-BRD4 complex: potential drug target for basal-like breast cancer.SOX9 drives WNT pathway activation in prostate cancer.SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.Wnt signaling in triple-negative breast cancer.Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.Master regulators in primary skin fibroblast fate reprogramming in a human ex vivo model of chronic wounds.Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9.ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.Hyperlipidemia induces vascular smooth muscle cell proliferation involving Wnt/β-catenin signaling.Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females.Dramatic dysbalancing of the Wnt pathway in breast cancers.
P2860
Q26740086-6DBD7566-3802-4254-8930-F21CEAD808E9Q28387589-B64B461D-34D8-4886-9C8F-3B5574E22FABQ33276544-579488C9-C4AE-43A5-A645-99C3709E07B5Q33976991-779023B0-44BF-44C5-B439-F409A4071123Q34121370-150B96ED-C4A5-4497-81B0-C8A32E80C890Q34495729-A3576780-5E08-4D85-9733-2CA79FE8D988Q34978975-E66C3FE8-6EA4-442C-B730-FCA96A8F8B4AQ35039889-745372D7-36D9-49E4-8095-A481D96C8FF4Q36299781-ABEEEC5A-0A22-4F72-8595-4256820BA0F9Q36835178-C5835BFB-988D-49E6-9071-98ED42DCF194Q37190152-1838A27F-9CF3-454B-9BE0-BB4FAA5B457BQ37301823-A15AF9E5-C886-4A8D-9AA2-4E02406C853DQ38288525-CB47D365-DD9F-440B-9772-D1DB47469444Q38780862-9816A576-8953-4E43-AC12-29AC4947DE38Q38906000-40E0926C-6779-424F-8873-10890BEF7C73Q39214992-40AD1222-D839-4495-9EE0-5AA35E51A5B5Q42030667-9E52A013-2259-4A10-9D39-3FCB2D998E57Q44603877-29D87691-0FBD-44A9-9274-C08F2356F3E5Q46028248-71DB77B1-0955-422E-B30A-44613E2B50B4Q47095936-949F3800-2D0B-4CE7-8243-8B1FCA731DADQ47333890-1B3184A5-873F-47A7-BD12-9159B0D82D09Q48020980-8C87F01E-86BB-49BC-8782-464E96A7C814Q48480092-21F79C80-9155-4691-8D64-DE54078AEAD8Q52918848-5684F899-2678-4791-B2D9-06F78532D34EQ54090659-8A13CF62-AC6D-4527-A5B2-ED3959F05203Q54943418-C3ABBA35-3ED9-40C4-B72D-5913E95543E9
P2860
SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
SOX9 regulates low density lip ...... n activation in breast cancer.
@ast
SOX9 regulates low density lip ...... n activation in breast cancer.
@en
type
label
SOX9 regulates low density lip ...... n activation in breast cancer.
@ast
SOX9 regulates low density lip ...... n activation in breast cancer.
@en
prefLabel
SOX9 regulates low density lip ...... n activation in breast cancer.
@ast
SOX9 regulates low density lip ...... n activation in breast cancer.
@en
P2093
P2860
P356
P1476
SOX9 regulates low density lip ...... n activation in breast cancer.
@en
P2093
Andrea L Richardson
Hongyun Wang
Lingfeng He
Meredith M Regan
Steven P Balk
P2860
P304
P356
10.1074/JBC.M112.419184
P407
P577
2013-01-10T00:00:00Z